uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Is erythromycin therapy teratogenic in humans?
Uppsala University, Medicinska vetenskapsområdet, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
2005 (English)In: Reprod Toxicol, ISSN 0890-6238, Vol. 20, no 2, 209-14 p.Article in journal (Other scientific) Published
Place, publisher, year, edition, pages
2005. Vol. 20, no 2, 209-14 p.
Keyword [en]
Adult, Confidence Intervals, Erythromycin/*therapeutic use/*toxicity, Female, Heart Defects; Congenital/*epidemiology/*etiology, Humans, Infant; Newborn, Interviews, Odds Ratio, Pregnancy, Pyloric Stenosis/epidemiology/etiology, Registries, Retrospective Studies, Risk Factors, Sweden/epidemiology, Teratogens/*toxicity
Identifiers
URN: urn:nbn:se:uu:diva-26188PubMedID: 15907655OAI: oai:DiVA.org:uu-26188DiVA: diva2:53962
Available from: 2007-02-15 Created: 2007-02-15 Last updated: 2011-01-12

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15907655&dopt=Citation

Authority records BETA

Danielsson, Bengt R

Search in DiVA

By author/editor
Danielsson, Bengt R
By organisation
Department of Pharmaceutical Biosciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 388 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf